WARSAW, Ind., Aug. 29, 2024 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2024. The cash dividend of $0.24 per share is payable on or about October 31, 2024 to stockholders of record as of the close of business on September 30, 2024.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.twitter.com/zimmerbiomet.
|
Media |
Investors |
|
Heather Zoumas-Lubeski |
Zach Weiner |
|
(445) 248-0577 |
(908) 591-6955 |
SOURCE Zimmer Biomet Holdings, Inc.
Opening of testing lab ushers in a new era of targeted treatments to change glioblastoma…
Toronto, Ontario--(Newsfile Corp. - August 29, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the…
Promotions expand C-suite leadership as company transitions to commercial operation and commences development of large-scale…
Zepp Health's Amazfit & HYROX Announce Partnership Reaching Over 300,000Participants Per Season Across EU and…
FREMONT, Calif., Aug. 29, 2024 /PRNewswire/ -- THINK Surgical, Inc., an innovator in the field…
OGTN launch highlighted during National Suicide Prevention Awareness Month COLUMBUS, Ohio, Aug. 29, 2024 /PRNewswire/…